Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of an antiallergic investigational drug (Japan, jRCT2080223967)
jRCT2080223967Phase 1Completed
- Start
- Jul 2018
- Countries
- 1
01
Overview
Phase 1 trial in allergy. Started Jul 2018; status: completed.
02
Conditions
allergy
Beyond the preview
Go deeper on jRCT2080223967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223967.